What is it about?

Cysteamine prevents vascular leakage through inhibiting hyperglycemia-induced TGase activation in the retinas of diabetic mice, and thus it has therapeutic potential for preventing diabetic retinopathy and vascular leakage-associated diseases.

Featured Image

Read the Original

This page is a summary of: Cysteamine prevents vascular leakage through inhibiting transglutaminase in diabetic retina, Journal of Endocrinology, July 2017, Bioscientifica,
DOI: 10.1530/joe-17-0109.
You can read the full text:

Read

Contributors

The following have contributed to this page